Akums Drugs and Pharmaceuticals has licensed the manufacture and commercialisation of bempedoic acid, a lipid-lowering drug for heart disease patients.

Orally administered by statin-intolerant patients, bempedoic acid is a novel drug used to treat high LDL cholesterol conditions indicative of cardiovascular disease.

• Overnight Stock Market Movements: Key Developments 
• KPI Green Energy Shares Rally 5% on Bagging 120 MW Order 
• Surya Roshni Rises 2.7% on Demerger Reports, US Orders
• Benchmark Indices Fell 200 Points from day High
• Apollo Micro Systems Jumps 9% on Record FY26 Profit

“An estimated 112 million Indian adults have high LDL cholesterol levels, and large numbers of dyslipidemia patients receiving statin therapy continue to experience uncontrolled dyslipidemia for these patients, bebedoic acid is a silver lining,” Director Sandeep Jain said.